199 related articles for article (PubMed ID: 28480520)
1. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy.
Lim CC; Tung YT; Tan BH; Lee PH; Mok I; Oon L; Chan KP; Choo JC
Nephrology (Carlton); 2018 Jul; 23(7):676-681. PubMed ID: 28480520
[TBL] [Abstract][Full Text] [Related]
2. Risk-stratified approach to anti-viral prophylaxis against cytomegalovirus disease in glomerulonephritis and renal vasculitis treated with potent immunosuppressants.
Lim CC; Tan BH; Tung YT; Huang H; Hao Y; Mok IYJ; Lee PH; Choo JCJ
Infect Dis (Lond); 2019 Oct; 51(10):745-752. PubMed ID: 31407631
[No Abstract] [Full Text] [Related]
3. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
Santos CA; Brennan DC; Yusen RD; Olsen MA
Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population.
Takizawa Y; Inokuma S; Tanaka Y; Saito K; Atsumi T; Hirakata M; Kameda H; Hirohata S; Kondo H; Kumagai S; Tanaka Y
Rheumatology (Oxford); 2008 Sep; 47(9):1373-8. PubMed ID: 18577548
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.
Höcker B; Zencke S; Krupka K; Fichtner A; Pape L; Dello Strologo L; Guzzo I; Topaloglu R; Kranz B; König J; Bald M; Webb NJ; Noyan A; Dursun H; Marks S; Yalcinkaya F; Thiel F; Billing H; Pohl M; Fehrenbach H; Bruckner T; Tönshoff B
Transplantation; 2016 Apr; 100(4):862-70. PubMed ID: 26736017
[TBL] [Abstract][Full Text] [Related]
7. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients.
Ge S; Karasyov A; Sinha A; Petrosyan A; Lovato D; Thomas DL; Vo A; Jordan SC; Toyoda M
Transplantation; 2017 Jul; 101(7):1720-1726. PubMed ID: 27841845
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Morishita M; Sada KE; Matsumoto Y; Hayashi K; Asano Y; Hiramatsu Asano S; Ohashi K; Miyawaki Y; Katsuyama E; Watanabe H; Kawabata T; Wada J
PLoS One; 2019; 14(7):e0218705. PubMed ID: 31291263
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
Grossi P; Mohacsi P; Szabolcs Z; Potena L
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
[TBL] [Abstract][Full Text] [Related]
11. Low-dose valganciclovir for cytomegalovirus prophylaxis in intermediate-risk liver transplantation recipients.
Khan S; Sullivan T; Ali M; Dunn D; Patel G; Huprikar S
Liver Transpl; 2018 May; 24(5):616-622. PubMed ID: 29500912
[TBL] [Abstract][Full Text] [Related]
12. CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
Schulz U; Solidoro P; Müller V; Szabo A; Gottlieb J; Wilkens H; Enseleit F
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S5-10. PubMed ID: 26900992
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
Rea F; Potena L; Yonan N; Wagner F; Calabrese F
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S19-26. PubMed ID: 26900991
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience.
Bontà J; Zeitz J; Frei P; Biedermann L; Sulz MC; Vavricka SR; Scharl S; Fried M; Rogler G; Scharl M
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1329-34. PubMed ID: 27482785
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis.
Nahar S; Iraha A; Hokama A; Uehara A; Parrott G; Ohira T; Kaida M; Kinjo T; Kinjo T; Hirata T; Kinjo N; Fujita J
World J Gastroenterol; 2015 Nov; 21(44):12667-75. PubMed ID: 26640344
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality.
Torres HA; Kontoyiannis DP; Aguilera EA; Younes A; Luna MA; Tarrand JJ; Nogueras GM; Raad II; Chemaly RF
Clin Lymphoma Myeloma; 2006 Mar; 6(5):393-8. PubMed ID: 16640816
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
Pillet S; Pozzetto B; Roblin X
World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
[TBL] [Abstract][Full Text] [Related]
18. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
Yoshihara R; Komai T; Shoda H; Fujio K
Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia.
Yoda Y; Hanaoka R; Ide H; Isozaki T; Matsunawa M; Yajima N; Shiozawa F; Miwa Y; Negishi M; Kasama T
Mod Rheumatol; 2006; 16(3):137-42. PubMed ID: 16767551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
